NIAID is committed to the research necessary to successfully end HIV/AIDS. Each year, 50,000 people in the United States become infected with HIV, the virus that causes AIDS. Currently, there are an estimated 1.1 million people in the United States and 34 million people globally who are living with HIV infection. In 2011, 1.7 million people died from AIDS-related causes. Through our laboratories and clinics at the National Institutes of Health to our vast network of supported research at universities, medical centers, and clinical trial sites around the globe, NIAID is working to better understand HIV and how it causes disease, find new tools to prevent HIV infection, develop new and more effective treatments for HIV-infected people, and find a cure.
Media Availability: HVTN 505 Vaccine Induced Antibodies Nonspecific for HIV—July 30, 2015
The Path to a Cure for Hepatitis C in People with HIV—July 27, 2015
Media Availability: Two Paths Pave Way for Development of a Preventive HIV Vaccine—July 23, 2015
Media Availability: Study Finds PrEP Use Feasible Among High-Risk Groups in U.S. Community Settings—July 21, 2015
Young South African Women Can Adhere to Daily PrEP Regimen as HIV Prevention, Study Finds—July 20, 2015
News From NIAID-Supported Institutions
Browse illustrations and multimedia describing the basics of HIV/AIDS, clinical research that is underway, and scientific advances.
Last Updated July 30, 2015